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Abstract
Background: The study aimed to evaluate the combined effect of Pulsed Electromagnetic Field (PEMF) biophysical
stimulation and bone marrow concentrate (BMC) in osteochondral defect healing in comparison to the treatment
with scaffold alone.
Methods: An osteochondral lesion of both knees was performed in ten rabbits. One was treated with a collagen
scaffold alone and the other with scaffold seeded with BMC. Half of the animals were stimulated by PEMFs
(75 Hz, 1.5 mT, 4 h/day) and at 40 d, macroscopic, histological and histomorphometric analyses were
performed to evaluate osteochondral defect regeneration.
Results: Regarding cartilage, the addition of BMC to the scaffold improved cell parameters and the PEMF stimulation
improved both cell and matrix parameters compared with scaffold alone. The combination of BMC and PEMFs further
improved osteochondral regeneration: there was an improvement in macroscopic, cartilage cellularity and matrix
parameters and a reduction in the percentage of cartilage under the tidemark. Epiphyseal bone healing improved in all
the osteochondral defects regardless of treatment, although PEMFs alone did not significantly improve the
reconstruction of subchondral bone in comparison to treatment with scaffold alone.
Conclusions: Results show that BMC and PEMFs might have a separate effect on osteochondral regeneration, but it
seems that they have a greater effect when used together. Biophysical stimulation is a non-invasive therapy, free from
side effects and should be started soon after BMC transplantation to increase the quality of the regenerated tissue.
However, because this is the first explorative study on the combination of a biological and a biophysical treatment for
osteochondral regeneration, future preclinical and clinical research should be focused on this topic to explore
mechanisms of action and the correct clinical translation.
Background
Regenerative therapy for osteochondral lesions aims to
produce a durable cartilage-like and bone tissues with
the same structure and function as the native cartilage
and well integrated with the surrounding tissues [1].
However, until now, the traditional surgical strategies
have not been able to repair completely osteochondral
lesions, but often produce a fibrous or fibrocartilaginous
tissue that undergoes degeneration in the long term,
with reduced biological, biomechanical and biochemical
features [2].
Recently, tissue engineering (TE) approaches have
emerged in the scenario of orthopedics as a promising
alternative to overcome the limitations of traditional
surgery [3]. Among the different scaffolds, collagen-
based ones provide a natural cartilage and bone micro-
environment, which promote mesenchymal stem cell
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(MSC) or chondrocyte attachment, proliferation, activ-
ity and extracellular matrix (ECM) deposition [4].
A one-step TE procedure, based on the use of bone
marrow concentrate (BMC) transplantation, has gained
popularity because it overcomes the limits and risks of the
in vitro MSC expansion procedures (long times, costs, cell
transformation, contamination and unnatural differenti-
ation), usually performed to obtain a useful amount of
cells for scaffold colonization. BM cells can be harvested
easily from the patient’s iliac crest, concentrated directly
in the operating theatre and implanted arthroscopically
once seeded onto a scaffold, thus avoiding the need for
two surgical stages (one for cell harvesting and another for
implantation) [4]. In addition, autologous BMC carries
also accessory cells and several growth factors that induce
angiogenesis and vasculogenesis [5].
Hyaluronic acid and collagen have been used for
osteochondral regeneration in combination with BMC
for the regeneration of osteochondral lesions in patients.
Good results have been obtained independently of the
scaffold used in some cases [5, 6], whereas better results
have been reported with a collagen scaffold compared to
a hyaluronic acid membrane in others [7].
There is an increasing awareness of the importance of
the microenvironment where both scaffolds and cells are
transplanted. The inflammatory joint microenvironment,
produced by the lesion itself or subsequent to the surgical
procedure, should be considered as an important variable
that causes MSC differentiation towards a fibroblastic
phenotype and might also affect scaffold degradation [8].
The rationale for using Pulsed Electromagnetic Fields
(PEMFs) in association with TE strategies was recently sup-
ported by evidence of both an anabolic effect on implanted
cells and surrounding tissues and an anti-inflammatory ef-
fect protecting cells from the catabolic effects of inflamma-
tion [8]. Besides improvements in cartilaginous tissue
healing [8, 9], it has been observed that biophysical stimula-
tion with PEMFs, promotes osteochondral graft healing
and integration [10, 11]. Boopalan et al., showed the effect-
iveness of PEMF stimulation in hyaline cartilage formation
six weeks after the implantation of a calcium phosphate
scaffold in ostechondral defects in rabbits [12].
Therefore, the hypothesis of the present in vivo study was
that the combination of PEMF stimulation and the seeding
of BMCs onto a collagenous scaffold might have a potential
additive or synergic therapeutic effect in enhancing osteo-
chondral regeneration in comparison to scaffold alone.
We evaluated the regenerative potential through macro-
scopic, histological and histomorphometric analyses in a
rabbit model of osteochondral defect.
Methods
The study was performed according to European and
Italian legislation on animal experimentation (Law by
Decree No.116/92). The experimental protocol was ap-
proved by the Ethical Committee of Rizzoli Orthopaedic
Institute and Italian Ministry of Health. Ten adult male
New Zealand rabbits (about 5 months old, 3.0 ± 0.3 kg)
(HARLAN Laboratories SRL, Udine-Italy) were housed
under controlled conditions and supplied with standard
diets. General anaesthesia was induced with an intramus-
cular injection of 44 mg/kg ketamine (Imalgene 1000,
Merial Italia SPA, Padova-Italy) and 3 mg/kg xylazine
(Rompum, Bayer Italia SpA, Milan-Italy) and maintained
with O2 and air (0.5 l/min) mixed with 2-3 % Isofluoran
(Aerrane, Baxter S.p.A, Rome-Italy) in spontaneous
ventilation.
BMC isolation
Before joint surgery, 6.0 ± 1.5 ml of BM from the posterior
iliac crest of each animal was aspirated into a syringe
coated with saline-heparin solution and the needle was ro-
tated to prevent venous return. The samples were immedi-
ately sent to the laboratory and an equal volume of
physiological solution (Fresenius Kabi Italia s.r.l., Verona-
Italy) was added to the BM aspirate, then stratified on
Ficoll-Paque (density 1.083 g/ml) (Sigma-Aldrich, Milan-
Italy) and subsequently centrifuged at 600 g for 30 min.
The low-density cellular layer was separated, counted and
resuspended in 200 μl of physiological solution for immedi-
ate surgical implantation.
Joint surgery
Through a lateral knee arthrotomy, an osteochondral
defect of 4 × 4 mm was performed in the loading area of
both medial femoral condyles with a dimension compar-
able to that of a clinical microfracture [13]. In each animal,
one defect was filled with a scaffold (BIOPAD, Novagenit,
Trento-Italy) consisting of heterologous equine type I col-
lagen, and the other one with the scaffold seeded with
BMC (2.03 × 106 BM mononuclear cells). The joint cap-
sule and skin were sutured and after surgery the animals
received antibiotics, 30 mg/Kg of Flumequine (Flumexil,
Fatro SpA, Bologna-Italy) for 4 d and analgesics, 80 mg/Kg
of sodium metamizole (Farmolisina, Ceva SpA, Monza-
Italy).
From the first post-operative day, half of the animals
underwent biophysical PEMF stimulation with 1.5 mT,
75 Hz (I-ONE, Igea SpA, Modena-Italy) 4 h/day until
the end of the experimental time. Two solenoids, posi-
tioned at the level of articulations, were placed outside
Plexiglas cages and connected to a pulsed generator.
The same conditions were maintained also in the other
half of the animals, but without the activation of the
generator (not stimulated animals).
After 40 d, under general anaesthesia, the animals
were pharmacologically euthanized with intravenous
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injection of 1 ml Tanax (Hoechst AG, Frankfurt-am-
Mein-Germany).
Four groups of five treated knees were examined:
Group 1 (scaffold), Group 2 (scaffold seeded with BMC),
Group 3 (scaffold and PEMFs), and Group 4 (scaffold
seeded with BMC and PEMFs).
Post-surgical evaluations
The Niederauer score was used for gross morphological
evaluation [14].
Both condyles of all animals were processed and sec-
tioned as in a previous study [15]. For each sample three
consecutive central sections of the entire volume of the
lesion were stained with Safranin-O/Fast Green. Histo-
logical analysis was performed by a light optical micro-
scope (Olympus-BX51, Italia Srl, Milan-Italy), equipped
with a camera and connected to an imaging analysis sys-
tem (Leica QWIN, Leica Microsystems Srl, Milan-Italy).
A semi-quantitative O’Driscoll modified grading score
[16] was used to evaluate both cartilage and bone com-
partments by two blinded investigators (Table 1).
The amount of new cartilaginous tissue, over and
under the tidemark, was calculated in a region of inter-
est (ROI) inside the osteochondral defect [17]. The per-
centage (%) of new cartilage, obtained by binarizing the
area of positive Safranin-O staining, was calculated as
(new cartilage area/ROI area) × 100.
Statistical analysis
Statistical analysis was performed using the IBM SPSS
Statistics v.21 software. After checking the normal
distribution and the homogeneity of the variance, the
non-parametric Kruskal-Wallis test was used to verify
if there were significant differences in the macro-
scopic and histomorphometric results among groups.
Then, the Mann–Whitney U test was evaluated by
the Monte Carlo method to compute two-sided
Table 1 Scoring parameters for histological evaluations (modified O’Driscoll score)
Tissue Parameters Score
0 1 2 3 4
Cartilage
(Min-Max: 0–31)





Matrix staining None Slight Moderate Normal
Surface regularity Disrupted surface Fissuring Horizontal lamination
of surface
Smooth and intact











Not bonded Partially bonded at
both ends or bonded
at one end
Bonded at the both
ends
Chondrocyte clustering 25-100 % of the
cells
<25 % of cells is
grouped in clusters
No clusters
Hypocellularity Severe Moderate Slight Normal




in the adjacent native
cartilage
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probability to compare the results of Group 2, Group
3 and Group 4 with Group 1.
Results
Macroscopic evaluations
No surgical or post-operative complications were ob-
served and the animals tolerated both surgery and PEMF
stimulation well. The Group 1 defects were partially
empty with a rough brown fibrous tissue surface and a
slight depression in the center and those of Group 2 ap-
peared translucent with a high degree of filling and inte-
gration. In both cases the margins of the lesion were
almost indistinguishable. Group 3 presented irregular-
ities in the well-integrated and barely noticeable surface
that was approximately filled up to the level of adjacent
cartilage and those of Group 4 were filled with a fully-
integrated and transparent cartilage-like tissue, quite in-
distinguishable from normal adjacent tissue.
The total and subcategories Niederauer score showed
significantly higher values in Group 4 in comparison
with Group 1 (p < 0.05), except for the surface smooth-
ness parameter (Fig. 1).
Histological and histomorphometric evaluations
Forty days after surgery, the scaffold was no longer
recognizable in any of the Groups and no inflammatory
cells or fibrous capsules were found regardless of
treatment.
The Group 1 defects were characterized by the pres-
ence of a fibrocartilage, with a poor glycosaminoglycan
(GAG) staining, an altered distribution of chondrocytes,
grouped in clusters, and zones of hypocellularity (Fig. 2a).
Group 2 showed a fibrocartilage with a normal cell dis-
tribution, few clusters and slight hypocellularity (Fig. 2b).
After PEMF stimulation, the repaired tissue of Group 3
was a mix of hyaline cartilage and fibrocartilage with
moderate matrix staining, slight fibrillation and some
clusters of chondrocytes in a few zones (Fig. 2c). Group
4 defects presented mainly hyaline cartilage, with a nor-
mal GAG content, nearly smooth surface, no clusters,
no hypocellularity and cells with a columnar aspect
(Fig. 2d). In all Groups, both edges were integrated with
the adjacent cartilage, which appeared normal with no
signs of degeneration. In Group 4 bone reconstruction
was complete.
Table 2 and Fig. 3 show the modified O’Driscoll score
results.
Considering the effect of BMC, the total modified
O’Driscoll score was significantly higher in Group 2 than
in Group 1 (p < 0.05), with an improvement in hypocellu-
larity (p < 0.005), cell distribution (p < 0.05), bone infiltra-
tion (p < 0.005) and the other bone parameters (p < 0.05).
Regarding PEMF effect, the total modified O’Driscoll
score was significantly higher in Group 3 than in Group 1
(p < 0.05), with low hypocellularity (p < 0.005) and better
tissue morphology (p < 0.05) and bone microarchitecture
parameters (p < 0.005), except for the reconstruction of
bone parameters.
Group 4 showed a significantly higher modified O’
Driscoll score (p < 0.05) than Group 1, concerning
matrix staining, neocartilage alignment (p < 0.05), hypo-
cellularity and cell distribution (p < 0.005) and bone
parameters (p < 0.005).
Finally, the percentage of cartilage under the tide-
mark was significantly lower in Group 4 than in
Group 1 (p < 0.05) (Fig. 4).
Discussion
This study evaluated the separate and combined effect
of BMC implantation and PEMF stimulation on
Fig. 1 Niederauer score results of macroscopic evaluations (Mean ± SD, n = 5). Mann–Whitney U test (p < 0.05): *, Group 4 versus Group 1
Veronesi et al. BMC Musculoskeletal Disorders  (2015) 16:233 Page 4 of 8
Fig. 2 Histological images of the osteochondral lesions: a Group 1 – scaffold; b Group 2 – scaffold seeded with BMC; c Group 3 – scaffold and
PEMFs; d Group 4 –scaffold seeded with BMC and PEMFs. H =Hypocellularity; C = Chondrocyte cluster. Safranin-O/Fast Green staining. Magnification of 4X
Table 2 Results of each parameter of modified O’Driscoll score (Mean, n = 5)
Tissue Parameters No PEMF PEMF treated
Group 1 Group 2 Group 3 Group 4
Cartilage Tissue morphology 1.4 1.6 2.6c 2.6
Matrix staining 1.2 1.8 1.8 3.4e
Surface regularity 2.2 2.6 2.4 2.6
Structure integrity 1.4 1.6 1.6 2.0
Neocartilage alignment 0.8 1.6 1.2 2.4e
Chondrocyte clustering 1.8 2.0 1.2 2.0
Hypocellularity 0.8 2.0b 2.0d 3.4f
Degenerative changes in adjacent cartilage 2.8 3.0 2.8 3.0
Bonding to native cartilage 2.0 2.0 2.0 2.0
Cell distribution 0.6 2.6a 1.0 3.4f
Thickness of neocartilage 1.8 2.0 1.6 2.0
Tidemark continuity 1.0 1.0 0.8 1.0
Bone Reconstruction of subchondral bone 1.2 2.6a 1.4 3.0f
Bone infiltration 1.0 2.0b 1.6c 2.0f
Bonding with adjacent bone 1.2 2.8a 2.8c 3.0f
Subchondral bone morphology 1.6 2.6a 3.2c 3.6f
Mann–Whitney U test: a, Group 2 versus Group 1 (p < 0.05); b, Group 2 versus Group 1 (p < 0.005); c, Group 3 versus Group 1 (p < 0.05); d, Group 3 versus Group 1
(p < 0.005); e, Group 4 versus Group 1 (p < 0.05); f, Group 4 versus Group 1 (p < 0.005)
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osteochondral healing potential of collagenous scaf-
fold alone.
Besides cartilage, the bone compartment was also
assessed because proper bone healing influences the
long-term articular cartilage repair, with high quality and
smoother surface, gives mechanical support for both car-
tilage formation and lateral integration and protects car-
tilage from loss and stresses [18].
Seeding BMC on the scaffold improved the cartilage
cellularity parameters of the modified O’Driscoll
score, because BM cells are able to undergo a chon-
drogenic differentiation once implanted in the joint
microenvironment and influence the microenviron-
ment through a paracrine effect. Similar results were
also observed in previous studies where enhanced
healing of equine and mini-pig osteochondral defects
was obtained with BMC [19, 20].
PEMF stimulation significantly improved not only car-
tilage cellularity, but also the neo-tissue morphology,
whereas the combination of PEMFs and BMC improved
their separate effects: macroscopic appearance, cellular-
ity, neo-tissue staining and alignment were significantly
better and the amount of cartilage under the tidemark
was significantly reduced when PEMFs were combined
with BMC in comparison to scaffold alone. The amount
of cartilage under the tidemark is an index of subchon-
dral bone regeneration, because the less the subchondral
bone defect is filled by cartilage or fibrous tissue, the
Fig. 3 Modified O’Driscoll score results of cartilage and bone tissues (Mean ± SD, n = 5). Mann–Whitney U test (p < 0.05): *, all Groups versus
Group 1
Fig. 4 Percentage of new cartilage growth over and under the tidemark (Mean ± SD, n = 5). Mann–Whitney U test (p < 0.05): *, (new cartilage
growth under the tidemark) Group 4 versus Group 1
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more it is filled by bone [17]. The histological parame-
ters of bone improved, regardless of treatments, even if
only the reconstruction of subchondral bone in Group 3
was similar to that of Group 1. In agreement with litera-
ture data [18], in this study the improvement of bone
was associated not only with a better trabecular bone
architecture, but also an improvement in cartilage cellu-
larity, structure, alignment and ECM component synthe-
sis, thus confirming that a proper bone regeneration
contributes to a better cartilage repair.
It is also important to underline that lateral integration
of neocartilage and attachment to the underlying bone
occurred in all the treated groups.
In the current study a scaffold already used with good
results in clinical practice was implanted, to measure the
effect of BMC and PEMFs and to avoid the variability of
innovative scaffolds and to easily translate our research re-
sults to patients. Forty days after surgery, the scaffold was
no longer present in any treatment group but was replaced
by more or less mature cartilage and bone tissues.
In the treatment of osteochondral defects several stud-
ies have evaluated separately the biophysical stimulation
[10, 12] and BMC implantation technique [4, 19, 20] but
to our knowledge, there is a lack of preclinical data on
the combined effects of the cell therapy and PEMFs on
osteochondral defect regeneration. In addition, a previ-
ous in vitro study by Wang Q et al. also underlined the
effects of PEMF on MSC osteogenic differentiation as a
new TE technique to be employed before the in vivo use
of MSC for bone regeneration [21]. The authors
observed the osteogenic differentiation of amniotic epi-
thelial cells, as the MSC source, thus showing that the
combination of PEMF stimulation and osteoinductive
medium improved cell osteogenic differentiation in com-
parison to their use separately [21]. In the scope of a lar-
ger project it was recently shown by Cadossi et al. that
PEMF stimulation improved recovery, pain control and
clinical outcome in patients treated with collagen scaf-
fold combined with BMC in osteochondral lesions of the
talus after 60 d of treatment [22]. The present in vivo
data strongly support the first clinical evidence with the
help of histological and histomorphometric analyses, but
the short-term follow-up and the single experimental
time do not allow further maturation or gradual deteri-
oration of the regenerated tissues to be observed. In
addition, a mechanistic explanation of the PEMF effects
has to be explored in other specific studies with an
appropriate set-up.
Conclusions
The results suggest that a TE approach, represented by
BMC seeding on a collagen scaffold, combined with low-
frequency PEMF stimulation, rather than separately, im-
proves osteochondral regeneration, thus confirming the
hypothesis of the study. Even if all treatments signifi-
cantly enhanced bone architecture, only the combined
use of BMC and PEMF stimulation improved cartilage
cellularity and matrix GAG content, the macroscopic
appearance and the percentage of cartilage under the
tidemark. Biophysical stimulation is a non-invasive ther-
apy, free from side effects and should be started soon
after BMC transplantation to increase the quality of the
regenerated tissue. However, because this is the first ex-
plorative study on the combination of a biological and a
biophysical treatment for osteochondral regeneration,
future preclinical and clinical research should focus on
this topic to explore mechanisms of action and the cor-
rect clinical translation.
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